Debt-to-equity of Evelo Biosciences, Inc. from 30 Sep 2018 to 30 Sep 2023

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Evelo Biosciences, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2018 to 30 Sep 2023.
Evelo Biosciences, Inc. Debt-to-equity for the quarter ending 30 Sep 2023 was -241%, a 129% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Evelo Biosciences, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2023	-241%	-1077%	-129%	30 Sep 2023
Q2 2023	-409%	-928%	-179%	30 Jun 2023
Q1 2023	2317%	+1948%	+528%	31 Mar 2023
Q4 2022	1287%	+1124%	+694%	31 Dec 2022
Q3 2022	836%	+699%	+512%	30 Sep 2022
Q2 2022	519%	+405%	+356%	30 Jun 2022
Q1 2022	369%	+275%	+291%	31 Mar 2022
Q4 2021	162%	+55%	+51%	31 Dec 2021
Q3 2021	137%	+57%	+72%	30 Sep 2021
Q2 2021	114%	+54%	+89%	30 Jun 2021
Q1 2021	94%	+47%	+101%	31 Mar 2021
Q4 2020	107%	+76%	+249%	31 Dec 2020
Q3 2020	79%	+56%	+237%	30 Sep 2020
Q2 2020	60%	+41%	+214%	30 Jun 2020
Q1 2020	47%	+30%	+185%	31 Mar 2020
Q4 2019	31%	+7%	+30%	31 Dec 2019
Q3 2019	24%	-19%	-45%	30 Sep 2019
Q2 2019	19%			30 Jun 2019
Q1 2019	16%			31 Mar 2019
Q4 2018	24%			31 Dec 2018
Q3 2018	43%			30 Sep 2018

* An asterisk sign (*) next to the value indicates that the value is likely invalid.